Ursus Capital
London investment holding company of Colin Kingsnorth, incorporated 2021; listed as a single family office with healthtech and biotech interests.
USEFUL FOR Co-investors
Family & background
- HEADQUARTERS
- London, United Kingdom
- FOUNDED
- 2021
Investment approach
- ROUTES
- Direct investments
Overview
Ursus Capital Limited was incorporated in London in January 2021, with Colin Kingsnorth and Jane Glynn as directors; its registered activities are other holding companies and security dealing on own account. The firm's website refuses automated access, so its portfolio could not be checked; the single-family-office classification, direct investing and healthtech/biotech focus come from the import.
People
Classification
Single Family Office. Manages one family's own capital, with no outside investors. The family bears every loss. How family capital is classified →
FAQ
Ursus Capital is a single family office based in London, the United Kingdom, founded in 2021.
Ursus Capital invests directly in companies.
Ursus Capital invests in HealthTech and Biotech & Life Sciences.
Key people at Ursus Capital include Colin Kingsnorth (Founder and Director), Jane Glynn (Director), Mark Holme (Business Partner) and Andrew Pegge (Co-Investor).